Nanotechnology and Nanobiology Against Multi-drug Resistant Bacteria

BioDesign Research, a Science Partner Journal, is now considering submissions for a special issue: Nanotechnology and Nanobiology Against Multi-drug Resistant Bacteria.

Scope

The emergence of multidrug-resistant bacteria is a global threat. In the absence of available treatments, alternative therapies are needed. Nanotechnology and nanobiology, from nanoparticles to bacteriophages, are promising tools to combat superbugs. In this special issue, the aim is to provide an overview of new technologies and approaches that will contribute to design novel antimicrobials.

Topics of particular interest include, but are not limited to:

  • Nanotechnology and nanobiology to combat antimicrobial resistance
  • Phage and phage-derived therapies
  • Nanoparticles
  • New challenges against multi-drug resistant bacteria

    Special Issue Editor

    Pilar Domingo-Calap, PhD
    BioDesign Research Associate Editor
    Institute for Integrative Systems Biology
    University of Valencia, Spain
    www.uv.es/docapi

      Submission Deadline

      May 31, 2023

        Submission Instructions

        Visit the Author Guidelines for full details. When submitting, please select the special issue topic as the Section/Category and indicate in your cover letter that your submission is intended for inclusion in the Nanotechnology and Nanobiology Against Multi-drug Resistant Bacteria special issue.